| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.63 | 0.02 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.43 | 0.2 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.3 | 0.1 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.28 | 0.2 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.22 | 0.2 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.18 | 0.3 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.16 | 0.4 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.15 | 0.3 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.15 | 0.6 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.14 | 0.01 |